Previous Article | Next Article 
Journal of Virology, July 2000, p. 5886-5895, Vol. 74, No. 13
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Role of NH2- and COOH-Terminal Domains
of the P Protein of Human Parainfluenza Virus Type 3 in Transcription
and Replication
Bishnu P.
De,*
Michael A.
Hoffman,
Suresh
Choudhary,
Clayton C.
Huntley, and
Amiya K.
Banerjee*
Department of Virology, Lerner Research
Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195
Received 20 January 2000/Accepted 6 April 2000
 |
ABSTRACT |
The phosphoproteins (P proteins) of paramyxoviruses play a central
role in transcription and replication of the viruses by forming the RNA
polymerase complex L-P and encapsidation complex (N-P) with
nucleocapsid protein (N) and binding to N protein-encapsidated genome
RNA template (N-RNA template). We have analyzed the human parainfluenza
virus type 3 (HPIV3) P protein and deletion mutants thereof in an in
vitro transcription and in vivo replication system. The in vitro system
utilizes purified N-RNA template and cell extract containing L and P
proteins coexpressed via plasmids using a recombinant vaccinia virus
expression system. The in vivo system takes advantage of minigenome
replication, which measures luciferase reporter gene expression from
HPIV3 minigenomes by viral proteins in a recombinant vaccinia virus
expression system. These studies revealed that the C-terminal
20-amino-acid region of P is absolutely required for transcription in
vitro and luciferase expression in vivo, suggesting its critical role
in viral RNA synthesis. The N-terminal 40-amino-acid region, on the
other hand, is essential for luciferase expression but dispensable for
transcription in vitro. Consistent with these findings, the C-terminal
domain is required for binding of P protein to the N-RNA template
involved in both transcription and replication, whereas the N-terminal domain is required for the formation of soluble N-P complex involved in
encapsidation of nascent RNA chains during replication.
Coimmunoprecipitation analysis showed that the P protein forms a stable
homooligomer (perhaps a trimer) that is present in L-P and N-P
complexes in the higher oligomeric forms (at least a pentamer).
Interestingly, coexpression of a large excess of N- or C-terminally
deleted P with wild-type P had no effect on minigenome replication in
vivo, notwithstanding the formation of heterooligomeric complexes.
These data indicate that P protein with a deleted terminal domain can function normally within the P heterooligomeric complex to carry out
transcription and replication in vivo.
 |
INTRODUCTION |
Human parainfluenza virus type 3 (HPIV3) is a paramyxovirus and a significant cause of lower respiratory
illness, such as bronchiolitis and pneumonia in newborns and infants
(4, 31). The nonsegmented negative-strand RNA genome of
HPIV3 is 15,461 nucleotides long and is tightly encapsidated by the
nucleocapsid protein N (68 kDa) to form a helical nucleocapsid (2,
20, 22). Associated with this are the two virus-encoded proteins, the large subunit L (257 kDa) of the RNA-dependent RNA polymerase complex and the phosphoprotein P (90 kDa), forming a ribonucleoprotein (RNP) complex (2, 20, 22). Consistent with its encapsidation function, N is present in abundance (2,600 molecules), whereas the L
and P proteins are present in lesser amounts (30 and 300 molecules,
respectively) in the RNP of a virion (30). The L and P
proteins together constitute the RNA-dependent RNA polymerase complex
(L-P) that transcribes the genomic RNA encapsidated by N protein but
not the naked RNA (2, 20, 22). In the case of HPIV3,
cellular actin is also required for mRNA synthesis both in vitro and in
vivo (14, 15, 25). Moreover, the same RNA polymerase complex
or a modified form appears to be involved in replication, a process
that synthesizes full-length plus-strand genome RNA, which in turn
serves as the template for synthesis of minus-strand genome RNA to be
packaged into progeny virions (17).
The P proteins of nonsegmented negative-strand RNA viruses appear to be
multifunctional and have been found to exist as homooligomers (7,
12, 23, 36). Although no enzymatic activity has been detected in
P, it acts as a transactivator of L, which is the catalytic subunit of
the RNA polymerase complex. The L protein is also believed to contain
posttranscriptional modification activities such as capping,
methylation, and polyadenylation of mRNAs (1). The L protein
by itself cannot bind to the N-RNA template for initiation of RNA
synthesis; it does so efficiently only by forming the L-P complex
(29, 34). The P protein also plays an important role in
encapsidation of the nascent RNA chains during genome replication. It
interacts with the nucleocapsid protein N, thereby preventing
nonspecific encapsidation of cellular RNAs by the N protein. The
resulting soluble N-P complex participates in the encapsidation process
by which nascent plus- and minus-strand genome RNAs form the respective
RNPs during replication (11, 18, 28). It appears then that
the P protein forms multiple complexes in infected cells, such as L-P,
N-P, and P-P; these interactive processes presumably regulate the
ability of the RNA polymerase complex to transcribe or to replicate.
The P mRNA of HPIV3, like that of other paramyxoviruses, has the
capacity to encode multiple proteins (2, 20, 22). A basic
protein, designated C, is synthesized by translation of an alternate +1
open reading frame, and additional proteins, designated P-D and Pt, are
synthesized by an RNA-editing mechanism (21, 33); P-D and Pt
are N-coterminal with wild-type P but differ in the C-terminal region.
The precise functions of these additional P gene products in the virus
life cycle remains unknown, as are those of the L-P, N-P, and P-P
complexes in the normal life cycle of the virus. To begin to identify
various domains of interaction within the P protein of HPIV3, an in
vivo two-hybrid system was recently used to study N-P complex formation
(44). These studies demonstrated that both the N-terminal 40 amino acids (aa) and the C-terminal 20 aa of P are directly involved in
interaction with the N protein. In this respect, HPIV3 is similar to
vesicular stomatitis virus (VSV) (41), rabies virus
(19), and Sendai virus (10), in which both the N-
and C-terminal domains of P are similarly required for interaction with
their cognate N proteins. In the Sendai virus system, in addition, the
C-terminal domain of P appears to be involved in binding to the N-RNA
template, whereas the N-terminal domain functions as a chaperone for N, forming soluble N-P complex, which is presumably required during the
replication process (9, 39). Thus, it seems that the terminal domains of P play vital roles in regulating transcription and
replication of the genome RNA by their interactions with L and N-RNA
template and maintaining N in encapsidation-competent form.
To gain information on the role of P protein in the regulation of
transcription and replication in the HPIV3 system, which has remained
unexplored, we focused on the role of the terminal domains of P protein
in its interaction with the N-RNA template as well as the L and N
proteins. The transcription process was studied using a reconstituted
in vitro system, whereas replication was studied in vivo using a
recently developed HPIV3 minigenome replication system (27).
Protein-protein interaction was studied by coimmunoprecipitation of
epitope-tagged and untagged interacting proteins. It is evident from
these studies that the terminal domains of P play important regulatory
roles in viral transcription and replication, several of which appear
to be unique to HPIV3.
 |
MATERIALS AND METHODS |
Cells and viruses.
HPIV3 (HA-1, NIH 47885) was propagated in
CV-1 cells as described previously (14, 15). Recombinant
vaccinia virus expressing T7 RNA polymerase (vTF7-3) was grown in HeLa
cells. Protein expression and radiolabeling were performed in HeLa cells.
In vitro transcription.
HeLa cells in a six-well plate were
infected with vTF7-3 at a multiplicity of infection (MOI) of 3. At
1 h postinfection, the culture medium was replaced with a
transfection mix containing 20 µl of lipofectin combined with various
plasmid DNAs in Opti-MEM in a total volume of 1.5 ml. Unless otherwise
indicated, plasmids pHPIV3-P (pP), in which the initiation codon for C
protein is mutated, and pHPIV3-L (pL), both under the control of the T7
promoter in vector pGEM, were used at 2 µg of 200 ng per well,
respectively. At 5 h postinfection, the medium containing the
transfection mix was replaced with Dulbecco's modified Eagle's medium
(DMEM) containing 10% fetal bovine serum. At 24 h postinfection,
the cell monolayers were washed with ice-cold phosphate-buffered saline
(PBS) and harvested by scraping in PBS. The cells were pelleted by
centrifugation at 800 × g for 10 min. Cytoplasmic
extracts were prepared by lysing the cells in three cycles of freezing
and thawing in 40 µl of hypotonic buffer containing 10 mM Tris-HCl
(pH 8.0), 10 mM NaCl, and I mM dithiothreitol (DTT). Nuclei and cell
debris were removed by centrifugation for 5 min in an Eppendorf
centrifuge at 4°C. The soluble cytoplasmic extract was collected for
use in the transcription reaction. The protein concentration was
estimated as 5 mg/ml.
N-RNA templates were prepared from HPIV3-infected CV-1 cells
(108) following the procedure of Curran et al.
(10) with some modifications. Briefly, the cells were
harvested in PBS and resuspended in 5 ml of buffer containing 50 mM
Tris-HCl (pH 8.0), 0.15 M NaCl, 0.6% NP-40, 1% Triton X-100, and 1 mM
DTT. The cells were lysed by vortexing, and nuclei and cell membranes
were removed by centrifugation at 10,000 × g for 5 min. The cell extract was made 6 mM in EDTA and layered onto a 20 to
40% CsCl (wt/wt) gradient and centrifuged at 38,000 × g for 2 h at 12°C in an SW41 rotor. The visible N-RNA band
was collected and repurified using the CsCl gradient. Finally the N-RNA
was sedimented through 40% glycerol in 50 mM HEPES-KOH (pH 8.0)-50 mM
NaCl-0.2% NP-40-1 mM DTT onto a 100-µl cushion of 100% glycerol
and stored in liquid nitrogen.
The in vitro transcription reaction was performed in a 50-µl total
volume essentially as described previously (
15). The
reaction mixture contained 100 mM HEPES-KOH (pH 8.0), 100 mM KCl,
5 mM
MgCl
2, 1 mM DTT, 1 mM each ATP, GTP, and CTP, 10 µM UTP,
20 µCi of [

-
32P]UTP, 25 U of human placental RNase
inhibitor, 5 µg of actinomycin
D per ml, 2 µg of N-RNA, and, unless
otherwise stated, 10 µg of
cell extract containing coexpressed L and
P
proteins.
In vivo minigenome replication.
In vivo minigenome
replication was studied following the procedure of Hoffman and Banerjee
(27). Briefly, HeLa cell monolayers in 12-well plates, grown
to 90% confluency, were infected with recombinant vaccinia virus
vTF7-3, which expresses T7 RNA polymerase, at an MOI of 3. After 1 h at 37°C, the minireplicon, pHPIV3-MG(
), and support plasmids
pHPIV3P (pP), pHPIV3-L (pL), and pHPIV3-N (pN) were transfected using
lipofectin (Bethesda Research Laboratories) according to the
manufacturer's instructions. The plasmid amounts used were 200 ng of
pHPIV3-MG(
), 640 ng of pN, 700 ng of pP, and 100 ng of pL. After
4 h, the transfection medium was removed and replaced with 1 ml of
DMEM-5% fetal calf serum. At 28 h posttransfection, the
monolayers were lysed in 150 µl of lysis buffer, from which 1.5 µl
of lysate (equivalent to 2.3 × 103 cells) was then
used to determine luciferase activity in a Dynatech ML2250 luminometer
according to the manufacturer's specifications (luciferase assay kit;
Roche Biochemicals).
N-RNA binding assay.
Binding of wild-type (wt) P and
deletion mutants of P to the N-RNA template was performed using in
vitro reticulocyte lysate-translated and
[35S]methionine-labeled P proteins. The in
vitro-synthesized P proteins were clarified by layering onto 40%
glycerol (700 µl total volume) in 50 mM HEPES-KOH (pH 8.0)-50 mM
NaCl-1 mM DTT and centrifugation at 45,000 rpm for 1 h in
microcentrifuge tubes in an SW50.1 rotor. The clarified P from the top
of the glycerol cushion was analyzed by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis and quantitated by
phosphorimager. Equal amounts of radiolabeled P were incubated with 5 µg of purified N-RNA in 100 mM HEPES-KOH (pH 8.0)-100 mM KCl-5 mM
MgCl2-1 mM DTT at 30°C for 1 h. The reaction mixture was then layered onto a 40% glycerol cushion and centrifuged as described above. The N-RNA and P protein complex was directly dissolved in SDS-polyacrylamide gel sample buffer and analyzed. The
recovery of N-RNA was confirmed by staining with Coomassie blue
followed by fluorography.
Glycerol gradient analysis of proteins.
HeLa cell monolayers
in 100-mm plates were infected with vTF7-3 at an MOI of 3, and at
1 h postinfection the cells were transfected with N and wt or
mutant P-expressing plasmid DNAs (5 and 10 µg, respectively). At
24 h postinfection, the cells were harvested in PBS and
resuspended in 20 ml of hypotonic buffer containing 10 mM Tris-HCl (pH
8.0), 10 mM NaCl, and 1 mM DTT. The cells were lysed by four cycles of
freezing and thawing, and nuclei and cell debris were removed by
centrifugation in an Eppendorf centrifuge for 5 min at 4°C. Extracts
were layered onto linear 5 to 20% glycerol gradients prepared in
buffer containing 100 mM HEPES (pH 8.0), 150 mM NH4Cl, 5 mM
magnesium acetate, and 1 mM DTT and containing a 100-µl cushion of
100% glycerol, as described by Curran et al. (13).
Gradients were centrifuged in an SW60 rotor at 40,000 rpm for 20 h
at 4°C. Gradient fractions (300 µl) were collected from the top of
the tube, and 10-µl aliquots were analyzed in SDS-10%
polyacrylamide gels followed by Western blot with anti-RNP antibody and
detection of the proteins by enhanced chemiluminescence following the
manufacturer's protocol (Amersham).
Coexpression and immunoprecipitation of proteins.
HaLa cells
in a 12-well plate were infected with vTF7-3 at an MOI of 1. At 1 h postinfection, the cells were transfected with plasmid DNAs
expressing L or P proteins tagged with a stretch of eight amino acids
(DYKDDDDK) at the C terminus in combination with untagged P or N
protein using lipofectin (Gibco-BRL) in Opti-MEM. The quantities of
plasmid DNAs used for transfection are indicated in individual
experiments. At 12 h postinfection, the medium was replaced with 2 ml of methionine-free DMEM, and incubation was continued at 37°C. At
14 h postinfection, the cells were labeled with 50 µCi of
[35S]methionine in 1 ml of methionine-free DMEM for
6 h. Cells were washed with PBS, and cytoplasmic proteins were
extracted by treating the cell monolayers with 150 µl of luciferase
extraction buffer (Roche Biochemicals) for 12 min. An aliquot (50 µl)
was diluted with 750 µl of immunoprecipitation buffer and used for
immunoprecipitation with antiflag antibody conjugated to Sepharose
beads following the manufacturer's protocol (Sigma). For
immunoprecipitation with monoclonal anti-N antibody or anti-HPIV3
antibody (a generous gift from Ranjit Ray), the precipitation reaction
was carried out in buffer containing 25 mM Tris-HCl (pH 7.5), 50 mM
NaCl, 2 mM EDTA, and 5% sucrose using protein A-conjugated Sepharose beads. The immunoprecipitated proteins in the beads were boiled in
SDS-polyacrylamide gel sample buffer and analyzed in an SDS-10% polyacrylamide gel. The gel was stained with Coomassie blue, dried, and
subjected to fluorography.
 |
RESULTS |
Development of a reconstitution system for HPIV3 mRNA synthesis in
vitro.
HPIV3 transcription and replication are thought to follow
the general biosynthetic model proposed for the well-studied prototype viruses of the families Rhabdoviridae and
Paramyxoviridae, VSV and Sendai virus, respectively, in
which the L and P proteins constitute the active RNA polymerase complex
(2, 4, 20, 22, 31). In the case of HPIV3, methods for direct
demonstration of the role of L and P proteins in transcription and
replication has only recently been developed in vivo using a reverse
genetic system which relies mostly on the viral RNA polymerase-mediated replicative amplification of N-RNA template to detect mRNA synthesis (17). There was an additional need to develop an in vitro
transcription reconstitution system independent of genome replication
to study the role of L and P proteins in mRNA synthesis as well as the functions of various domains within these two proteins. Here we describe for the first time the development of such an in vitro transcription reconstitution system using purified N-RNA template and
recombinant L and P proteins. The N-RNA template depleted of endogenous
RNA polymerase was prepared from intracellular viral RNP by CsCl
gradient centrifugation as described in Materials and Methods. The L
and P proteins were coexpressed in HeLa cells using a recombinant
vaccinia virus expression system and optimized as described in a
recently developed minigenome replication system (27). At
24 h postinfection, cytoplasmic extract was prepared and used
directly in an in vitro transcription reaction containing purified
N-RNA template in the presence of [
-32P]UTP as the
labeled precursor, as described in Materials and Methods. The RNA
products were analyzed in a 5% polyacrylamide-urea gel followed by
autoradiography. As shown in Fig. 1A, the
N-RNA template alone had a low level of RNA-synthesizing activity,
presumably mediated by the residual template-bound RNA polymerase.
Addition of either L or P extract to the template had no significant
effect on RNA synthesis, while addition of extract containing
coexpressed L and P resulted in efficient synthesis of mRNAs which
increased linearly upon addition of increasing amounts of the later
extract, with a maximal stimulation of about 20-fold (Fig. 1B). Like
Sendai virus (6, 8), separate L and P extracts, when
combined in vitro, failed to activate transcription (data not shown)
while the extract containing coexpressed proteins did so efficiently where the P protein was required in stoichiometric amounts for efficient RNA synthesis. High-level expression of P under these conditions was confirmed by Western blot using anti-HPIV3 antibody (Fig. 1C), but L could not be detected due to the lack of a suitable antibody, although its expression can be monitored by appropriate tagging of the recombinant protein (see below). Thus, having developed the optimal in vitro transcription reconstitution conditions, we were
poised to study the role of the terminal domains (44) as
well as other biologically significant domains of P protein in the
transcription process in vitro.

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 1.
Requirement for L and P proteins for mRNA synthesis in
vitro. The L and P proteins were expressed either separately or in
combination in a recombinant vaccinia virus expression system. Cell
extracts were prepared at 24 h postinfection, and total protein
was estimated as about 2 mg/ml. (A) Equal amounts of protein (2 µg)
were used in in vitro transcription reactions containing purified N-RNA
template (2 µg) in the presence of [32P]UTP. (B)
Increasing amounts of protein (2, 4, 6, and 8 µg) containing
coexpressed L and P were used in the reactions. As a negative control,
8 µg of cell extract alone (L+P) was used in the reaction. The in
vitro-synthesized radiolabeled mRNAs were analyzed in a 5%
polyacrylamide-urea gel followed by autoradiography. (C) Western blot
of cell extracts using anti-RNP antibody. Mock, vaccinia virus-infected
and mock-transfected cell extract.
|
|
Essential role of the terminal domains of P in transcription in
vitro and replication in vivo.
To investigate the role of the
terminal domains of P in transcription, N- and C-terminally deleted P
proteins were coexpressed with L at optimal plasmid concentrations, and
cytoplasmic extracts were used directly in an in vitro transcription
reaction containing purified N-RNA template in the presence of
[
-32P]UTP. The RNA products were subsequently analyzed
in a 5% polyacrylamide-urea gel followed by autoradiography. As shown
in Fig. 2A, the C-terminally deleted P
mutants
10C and
20C were totally inactive in mRNA synthesis,
whereas the N-terminally deleted P mutants
20N and
40N were
highly active; specifically, P
40N was as active as wt P. The
expression levels of the wt and mutant P proteins were monitored by
Western blot with anti-HPIV3 antibody and found to be virtually similar
(Fig. 2B). These data indicate that 10 aa in the C-terminal domain of P
are required for mRNA synthesis, while a minimum of 40 aa at the
N-terminal domain are dispensable.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
Activity of mutant P proteins in transcription in vitro.
The N- and C-terminally deleted P proteins indicated were coexpressed
with L protein in a recombinant vaccinia virus expression system. (A)
Cell extracts (total protein, 6 µg) containing the coexpressed L and
P proteins were used in transcription reactions containing N-RNA
template in the presence of [32P]UTP, and the mRNA
products were analyzed in a 5% polyacrylamide-urea gel. (B) Western
blot of the cell extracts using anti-RNP antibody raised in rabbit that
recognized the HPIV3 N and P proteins. The migration positions of wt
and mutant P (Pwt and Pmut) and a nonspecific
host protein are shown. The data are representative of three separate
experiments with an experimental variability of <10%. Mock, vaccinia
virus-infected and mock-transfected cell extract.
|
|
To investigate the role of the terminal domains of P in replication, we
used the recently developed minigenome replication
system
(
27). As illustrated in Fig.
3, the minigenome is an
analog of the
HPIV3 negative-strand genome RNA in which the viral
genes have been
replaced with the luciferase reporter gene flanked
by the viral genomic
3' leader and adjacent N gene untranslated
region and 5' trailer and
adjacent L gene untranslated region.
The 5' end of the minigenome is
defined by the adjacent promoter
for T7 RNA polymerase, while the 3'
end is created by self-cleavage
by an abutting hepatitis delta virus
ribozyme. Cytoplasmic extracts
were prepared from cells that had been
infected with vTF7-3 and
transfected with the minigenome and support
plasmids, and an aliquot
was used for the luciferase enzyme assay as
described in Materials
and Methods. As shown in Fig.
3A, both
N-terminally deleted (40
aa) P and C-terminally deleted (20 aa) P
mutants were virtually
inactive in minigenome replication, although
expression levels
of wt and mutant P proteins were similar, as
determined by Western
blot with anti-HPIV3 antibody (data not shown).
This was confirmed
by primer extension analysis (
27), which
showed that both mutants
were inactive in the synthesis of replicated
and transcriptive
RNAs (Fig.
3B).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 3.
Activity of mutant P proteins in minigenome replication
in vivo. Terminally deleted P proteins were coexpressed with L and N in
the minigenome replication system containing pHPIV3-MG( ) plasmid as
described in Materials and Methods. At 24 h postinfection, cell
extracts were prepared and luciferase activity was measured. (Top)
Schematic representation of the minigenome replication assay. (A)
Expression of luciferase reporter gene by the supporting plasmids
expressing N, L, and wt or mutant P proteins. The background level of
luciferase activity (Luc. Act.) was determined by omitting the L
plasmid DNA, and the value was subtracted from the data. The data
represent the averages of three independent experiments, and standard
deviations are indicated as error bars. (B) Primer extension analysis
(27) of transcriptive (trans) and replicative (rep) RNAs in
the presence of various P proteins, as indicated. The primer used
anneals to the positive-sense luciferase coding sequence at the
initiating AUG codon. Lane ( )L, L plasmid DNA was omitted during
transfection. Lanes A, C, G, and T represent the sequencing ladder. T7
, T7 RNA polymerase transcription termination signal; Rz, hepatitis
delta virus ribozyme; le, leader; GS, gene start signal; GE, gene end
signal; tr, trailer (27).
|
|
Since the degree of inhibition of mRNA synthesis and replicated RNA
synthesis is similar, we conclude that the inhibition
most likely
occurs at the level of N-RNA template synthesis, because
the synthesis
of the template is dependent on initial encapsidation
of the T7 RNA
polymerase-transcribed minigenome RNA by the N protein,
followed by
virus polymerase-mediated replication. The N- and
C-terminally deleted
P mutants most likely affect one or both
of these
steps.
C-terminal domain of P required for N-RNA template binding, and
N-terminal domain required for soluble N-P complex formation.
Interaction of P with the N-RNA template is an initial step that
mediates the binding of RNA polymerase complex L-P to the template to
initiate both transcription and replication processes (29,
34). To study the role of terminal domains of P in this interaction, both wt and mutant P proteins were synthesized in vitro in
a reticulocyte lysate using coupled transcription-translation conditions and labeled with [35S]methionine. Equal
amounts of translated P proteins free of large protein aggregates were
then incubated with purified N-RNA under HPIV3 transcription
conditions. The radiolabeled proteins forming the complex with N-RNA
were pelleted by centrifugation through a 30% glycerol cushion and
directly analyzed in an SDS-10% polyacrylamide gel. As shown in Fig.
4, both wt and N-terminally deleted P
mutants
20N and
40N bound efficiently to the N-RNA, whereas
C-terminally deleted P mutants
10C and
20C bound only 15 to 20%
as well as wt P. Based on the fact that P
10C and P
20C failed to
mediate RNA synthesis in vitro and in vivo (Fig. 2 and 3), the low
level of binding of the mutants to the template possibly is not
sufficient for activating the RNA polymerase for RNA synthesis during
transcription and replication. Thus, it seems that the C-terminal 10-aa
region is crucial for binding to the N-RNA template and consequently in
transcription and replication.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of mutant P proteins to N-RNA template. The
terminally deleted P proteins were synthesized in a reticulocyte lysate
and labeled with [35S]methionine. Binding of labeled
proteins to N-RNA template (5 µg) was studied as described in
Materials and Methods. Binding of P proteins was determined by
phosphorimager quantitation of the P protein band after analysis in an
SDS-polyacrylamide gel, shown as an inset. The data are representative
of two separate experiments.
|
|
Specific requirement of the N-terminal domain in replication but not
transcription (Fig.
2 and
3) suggests that the defect
in P

40N is not
at the level of RNA synthesis per se, rather in
the encapsidation of
nascent RNA chains during replication. We
therefore investigated the
formation of encapsidation complex
(N-P) by coexpression of N and the P
proteins and subsequent analysis
by 5 to 20% glycerol gradient
centrifugation followed by Western
blot using anti-HPIV3 antibody as
described in Materials and Methods.
As shown in Fig.
5, coexpression of P

40N and N resulted
in no
detection of soluble N-P

40N complex (Fig.
5C); instead, both
proteins were detected in the pellet (data not shown), whereas
wt P
efficiently formed the complex, preventing N from sedimenting
as a
large aggregate in the pellet (Fig.
5A and B). Immunoprecipitation
of
the N-P complex using anti-N monoclonal antibody identified
about 1 to
5 P per N in the complex (data not shown). P

20C, on
the other hand,
efficiently formed the encapsidation complex with
N (Fig.
5D), which,
however, was not detected in the previously
used two-hybrid system in
vivo (
44), perhaps due to some defect
in its nuclear
translocation for activating the
cat gene. Thus,
it seems
that the inability of P

40N to form a complex with N
protein is
directly tied to its nonfunction in minigenome replication
in vivo
(Fig.
3). On the other hand, the primary reason for the
inability of
P

20C to function in transcription in vitro (Fig.
2) and minigenome
replication in vivo (Fig.
3) is its defect in
binding to the N-RNA
template.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 5.
Glycerol gradient analysis of encapsidation complex. The
wt and mutant P proteins were coexpressed with N in HeLa cells using
the recombinant vaccinia virus expression system as described in
Materials and Methods. Cell extracts were prepared at 24 h
postinfection, and the proteins were subjected to 5 to 20% glycerol
gradient centrifugation. The proteins in the gradient fractions, as
indicated, were resolved in an SDS-10% polyacrylamide gel and
detected by Western blot using anti-HPIV3 antibody. (A) Expression of N
alone. (B) Expression of P alone (top panel) and coexpression of N and
P (bottom panel). (C) Expression of P 40N alone (top panel) and
coexpression of N and P 40N (bottom panel). (D) Expression of P 20C
alone (top panel) and coexpression of N and P 20C (bottom panel).
Numbers above each panel indicate glycerol gradient fractions collected
from the top of the gradient. The migration positions of N and the wt
and mutant P proteins in the SDS-polyacrylamide gel are shown. Host,
host protein that nonspecifically reacted with the anti-HPIV3
antibody.
|
|
Role of terminal domains in P-P and L-P complex formation.
Since the P proteins of some members of the Rhabdoviridae
and Paramyxoviridae families have been shown to form dimers,
trimers, or tetramers (7, 12, 23, 36, 42), we were
interested in studying the oligomeric state of HPIV3 P protein by
coimmunoprecipitation of tagged and untagged P proteins. The P protein
was flag-tagged at the C terminus and coexpressed with a large excess
of untagged wt or mutant P proteins and metabolically labeled with
[35S]methionine. Radiolabeled soluble cytoplasmic
proteins were coimmunoprecipitated using antiflag antibody conjugated
to Sepharose beads, and the proteins were analyzed on an
SDS-polyacrylamide gel followed by fluorography. As shown in Fig.
6, coexpression of flag-tagged P with
increasing amounts of untagged P resulted in coprecipitation of
different amounts of untagged P in the oligomeric complex. The
flag-tagged P and untagged P, which were poorly separated and migrated
together in the gel as a closely spaced doublet, were quantitated.
Routinely, about two untagged P (1.4 to 1.9) per flag-tagged P were
seen, suggesting the formation of a P homooligomer, possibly a
homotrimer. The flag-tagged P was confirmed to be as active as the
untagged P in minigenome replication in vivo (data not shown). The role
of terminal domains in the P oligomerization was then studied by
coexpressing increasing amounts of P
40N and P
20C with the
flag-tagged P. P
40N was coprecipitated with flag-tagged P, and about
2 (1.3 to 1.6) P
40N were present per flag-tagged P, indicating that
P
40N efficiently formed a heterooligomer, possibly a heterotrimer.
In contrast, the C-terminally deleted P
20C was coprecipitated with
flag-tagged P in a significantly lower amount, indicating less
efficient incorporation into the complex. Phosphorimager quantitation
revealed that about 1 P
20C was present per 2 flag-tagged P (0.5 to
0.6 P
20C per flag-tagged P), suggesting that 2 flag-tagged P are
associated with 1 P
20C. The expression levels of P
40N and P
20C
were determined by Western blot using anti-HPIV3 antibody and found to
be similar (data not shown). Thus, it seems that the C-terminal domain
somehow plays a role in stabilizing a P subunit in the heterooligomer.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of P-P and L-P complexes in a flag-tagged
immunoprecipitation system. The proteins were coexpressed and
metabolically labeled with [35S]methionine. The labeled
proteins present in the cytosolic fraction were immunoprecipitated with
anti-flag antibody conjugated to Sepharose beads. The precipitated
proteins were analyzed in an SDS-10% polyacrylamide gel followed by
fluorography. (A) Analysis of P-P complex; 200 ng of flag-tagged P
(Pf) plasmid DNA was used in the transfection. Numbers
above the lanes indicate the amount of untagged mutant
(Pmut) and wt P protein-expressing plasmid DNA (in
micrograms) used for transfection. The ratios of untagged to
flag-tagged P proteins are shown below. (B) Analysis of L-P complex;
200 ng of flag-tagged L-expressing plasmid DNA (Lf) was
used in all transfections. The untagged wt and mutant P
protein-expressing plasmid DNAs, where indicated, were used at a
concentration of 1 µg each. The ratios of untagged P protein to
flag-tagged L in each case are shown below. Radiolabeled bands were
visualized by fluorography and quantitated by phosphorimager.
|
|
Next, we analyzed L-P complex formation, in which P has been shown to
be involved in protecting L against degradation as well
as in the
formation of active RNA polymerase complex (
6,
8,
40). We
coexpressed flag-tagged L and a large excess of wt P
protein, labeled
with [
35S]methionine, and immunoprecipitated using
anti-flag antibody.
The precipitated proteins were analyzed in an
SDS-10% polyacrylamide
gel and quantitated by phosphorimager. As
shown in Fig.
6, P was
coimmunoprecipitated with L, indicating stable
complex formation
between L and P. By quantitation, about 3 untagged P
proteins
were found to be present per flag-tagged L, based on the
presence
of 54 and 16 Met residues in the deduced sequences of the L
and
P proteins, respectively. The flag-tagged L was confirmed to be
as
active as the untagged L in minigenome replication in vivo
(data not
shown). These data again indicate that the P protein
is most likely
present in the L-P complex in the homotrimeric
state. On the other
hand, when P

40N was coexpressed with L, it
was efficiently
coprecipitated with L but with a P

40N-to-L stoichiometry
of 5:1. By
contrast, P

20C interacted with L poorly, displaying
a ratio of 1:1.
Together these data indicate that C-terminally
deleted P (defective in
N-RNA binding) oligomerizes less efficiently
and possibly interacts
with L mostly in the monomeric form, whereas
P

40N oligomerizes to a
higher degree (at least a pentamer) when
bound to L and is
transcriptionally active in
vitro.
Terminally deleted P proteins can function in minigenome
replication by forming heterooligomers with wt P.
The observation
that the N- and C-terminally deleted P proteins form heterooligomers
with wt P prompted us to investigate whether the heterooligomeric forms
of P can affect minigenome replication in vivo. Accordingly, we
cotransfected N- and C-terminally deleted P with wt P in the minigenome
replication system containing flag-tagged L. A low concentration of wt
P was used so that it would be sufficient for a basal level of
luciferase expression but suboptimal for supplemental function to
mediate efficient transcription and replication. The roles of N- and
C-terminally deleted P proteins were then investigated by
cotransfecting increasing amounts of plasmid DNAs expressing these
mutants. As shown in Fig. 7A, a basal
level of luciferase expression was detected by using an optimal
concentration of flag-tagged L and a low concentration of P (0.3 µg
of plasmid DNA). The activity was increased linearly to a maximum of
about threefold when the P-expressing plasmid DNA was progressively
increased to 1.2 µg, indicating that P is required in stoichiometric
amounts for efficient minigenome replication. Surprisingly,
cotransfection of increasing amounts of plasmid DNA expressing P
40N
had virtually no effect on the basal level of luciferase expression,
suggesting that the heterooligomer containing wt P and P
40N is
active in basal RNA synthesis but inert in the stoichiometric function
for efficient minigenome replication. By contrast, transfection of
plasmid DNA expressing P
20C, which presumably formed a heterotrimer,
showed increased expression of luciferase, which rapidly reached a
plateau, unlike that of wt P, indicating that the heterooligomer is
active, albeit at a low level, in the stoichiometric function. To
ascertain that the observed effect is specific and not due to an
alteration of protein expression, we performed Western blot analysis
using anti-RNP antibody. As shown in Fig. 7B, high-level expression of
N and P proteins (900 ng of plasmid DNA) was observed. Thus, it seems that both P
40N and P
20C can form a functional heterooligomer with
wt P but the former cannot perform the stoichiometric function of P,
whereas the latter does. It is important to mention that the increase
in luciferase expression correlated with increased mRNA and plus-sense
genome RNA synthesis, which was confirmed by primer extension analysis
(data not shown).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 7.
Stoichiometric requirement for P for efficient
minigenome replication, and role of terminal domains in this process.
(A) The complete minigenome replication system contained pHPIV3MG( )
(200 ng), pN (640 ng), pLf (200 ng), and pP at a suboptimal
concentration (300 ng). pP, pP 40N, and pP 20C (patterned bars from
left to right) were expressed, in addition to the components present in
the complete system (solid bar), as indicated above, in increasing
concentrations (300, 600, and 900 ng), and luciferase activity in the
cell extract was determined. (B) Western blot analysis of N and P
proteins using anti-RNP antibody that recognized the N and P proteins.
The migration positions of N and P are shown. A protein band migrating
faster than N may be a degradation product of P 40N. The amounts of
plasmid DNAs used are equivalent to the amounts indicated for the
complete system. In addition, lanes Pwt,
P 40N, and P 20C contained 900 ng of the
respective plasmid DNAs for transfection. (C) Immunoprecipitation of
radiolabeled proteins from cells that were transfected with plasmid
DNAs as described for panel B, except the first lane contained pLf
alone. Cells were metabolically labeled with
[35S]methionine and immunoprecipitated by using anti-flag
antibody conjugated to Sepharose beads. The precipitated proteins were
analyzed in an SDS-10% polyacrylamide gel and subjected to
fluorography. The data are representative of three separate experiments
with an experimental variability of <10%.
|
|
Finally, we examined whether the heterooligomers indeed interacted with
the L protein during minigenome replication. Cells
were transfected
with plasmids containing N, P, and flag-tagged
L and metabolically
labeled with [
35S]methionine followed by
immunoprecipitation using anti-flag antibody.
As shown in Fig.
7C, in a
control experiment, when a low concentration
of P (300 ng of plasmid
DNA) was present, a significant amount
of L was protected against
degradation, forming the L-P complex,
and the molar ratio was estimated
to be 1:1. A further increase
in P expression (1.2 µg of plasmid
DNA), as expected, resulted
in its increased binding to L, and the L-P
ratio was estimated
to be about 1:3. This confirms the notion that P
binds to L in
the monomeric form and subsequently oligomerizes. When
P

40N and
P

20C were expressed in molar excess (900 ng of plasmid
DNA) compared
to wt P (300 ng of plasmid DNA), they efficiently
interacted with
L to form a heterooligomeric L-P complex. However, we
noted that
the incorporation of wt P in such a complex was drastically
reduced
following coexpression with the mutant P proteins with a
subunit
composition of approximately
L-P-(P
mut)
2 (compare lane P
wt with
P
40N or P
20C in Fig.
7C). This confirms
that the mutant
P proteins indeed formed a functional heterooligomer
with wt P
to support minigenome replication. Thus, these data indicate
that
the mutant P proteins, when coexpressed with wt P, do not
interfere
with the wt P-dependent basal level of transcription and
replication.
However, the N-terminally deleted P (P

40N), which is
active in
mRNA synthesis in vitro (Fig.
2), cannot provide the
stoichiometric
function in vivo, as seen with wt P (Fig.
7A), whereas
the C-terminally
deleted P (P

20C), which is inactive in mRNA
synthesis in vitro
(Fig.
2), is able to provide the stoichiometric
function in vivo.
This suggests that the stoichiometric function of P
(wt P and
P

20C) observed in vivo in minigenome replication is most
likely
at the level of
encapsidation.
 |
DISCUSSION |
In this communication we describe the development of an efficient
in vitro transcription reconstitution system for HPIV3 using recombinant L and P proteins. In addition, replication in vivo was
studied using a recently developed minigenome replication system in our
laboratory (27). Using both these systems, we investigated
the role of the N- and C-terminal domains of P in viral mRNA synthesis
in vitro and replication in vivo. Our data indicate that both the N-
and C-terminal domains of P protein play important roles in these RNA
synthetic processes (Fig. 2 and 3); the N-terminal domain is primarily
involved in replication, whereas the C-terminal domain is involved in
both transcription and replication processes. Consistent with these
findings, the N terminus of P is required for interaction with N to
form soluble N-P complex. The C terminus, on the other hand, is
involved in the binding of P to N-RNA template as well as in
interaction with L protein to form stable L-P complex, where the P
protein appears to form stable homotrimers but was also identified in
the higher oligomeric forms when associated with L or N protein.
The in vitro transcription reconstitution system described here
confirms that HPIV3 L and P proteins, like Sendai virus (8), must be coexpressed for the formation of active RNA polymerase complex,
possibly to protect L from degradation (40). Using flag-tagging, we were able to detect L protein in the absence of P;
however, the level of L expression was increased significantly (about
fivefold) when coexpressed with the P protein, indicating the
protective role for P against L protein degradation. The coexpression studies further demonstrated that for optimal RNA synthesis,
stoichiometric amounts of P protein were needed
an observation similar
to that previously reported with VSV (13) and recently with
respiratory syncytial virus (16) and Sendai virus
(5). Thus, it is becoming increasingly apparent that the P
protein provides two important functions in RNA synthesis
(13); (i) formation of a complex with RNA polymerase L-P,
for which it is required in catalytic amounts, and (ii) interaction
with the N-RNA template to facilitate elongation of RNA chains, for
which it is required in stoichiometric amounts. However, it remains
unclear whether the stoichiometric function of P protein is manifested
while it is complexed with the L protein or independent of the L
protein. On the other hand, the minigenome replication system in vivo
relies on RNA synthesis as well as concurrent encapsidation of nascent
RNA chains during replication and thus provides a means to study the
differential role of P protein in RNA synthesis and encapsidation
during replication. Our observation that the P protein is also required
in stoichiometric amounts for luciferase reporter gene expression in
the minigenome replication system (Fig. 7A) raises the possibility
that the stoichiometric requirement for P in minigenome replication may
be both at the level of RNA synthesis and at the level of encapsidation
of nascent RNA chains during replication while complexed with the N protein.
When the terminally deleted P proteins were analyzed in the in vitro
transcription and in vivo minigenome replication, the C-terminal 10 aa
essential for interaction with N (44) were found to be
required for both transcription and replication (Fig. 2 and 3). Since
the C-terminal 10 aa are also involved in the binding of P protein to
the N-RNA template (Fig. 4), it can be concluded that the observed
defect is directly at the RNA synthesis step during both transcription
and replication, similar to that observed for VSV (24) and
Sendai virus (39). It is important to note, however, that
the Sendai virus P protein requires the C-terminal 30 aa for its
binding to the N-RNA template, and the N-RNA binding domain is mapped
within two noncontiguous boxes including the C-terminal 30 aa
(38). At the present time we do not know whether the N-RNA
binding domain of HPIV3 P also spans such noncontiguous domains.
Additional internal deletions are needed to pinpoint such a domain. It
is clear from the in vitro and in vivo results (Fig. 2 and 3) that the
N-terminal 40-aa region is required for replication but not
transcription, which is consistent with the N-terminal domain's being
involved in the formation of the N-P complex (Fig. 5) required for
encapsidation (9, 44). This suggests that the observed
defect of P
40N in minigenome replication in vivo is most likely at
the level of encapsidation of nascent RNA chains during the replication
process. Further studies are needed to directly confirm this
contention. Moreover, it would be interesting to determine whether
coexpression of P-D or Pt (normally synthesized by editing of P mRNA),
which contain the N-terminal domain but either differ at or lack the
C-terminal domain, can complement the P
40N defect in the
encapsidation process. Their participation in the encapsidation process
would suggest an additional regulation by these viral proteins in the
switch from transcription to replication by the RNA-editing mechanism.
Analyses of P-P and L-P complexes involved in RNA synthesis during
transcription and replication demonstrated that the HPIV3 P protein
expressed alone is capable of forming a stable homooligomer (Fig. 6)
similar to VSV (12, 23), Sendai virus (7), and HPIV2 (36). Our data suggest that the HPIV3 P protein forms a homotrimer, but this needs to be confirmed by a more sensitive technique similar to that recently used (42) to correctly
determine the Sendai virus P oligomeric state as a tetramer rather than the previously reported trimer (7). The oligomerization of the P proteins is predicted to occur via a specific coiled-coil domain
present in the P protein (7). Such a domain has been reported to be present in influenza virus HA (3, 43),
reovirus cell attachment protein
1 (32), clathrin
triskelion (35), and heat shock transcription factor
(37). In all of these cases the oligomerization of the
protein is thought to be essential for the manifestation of its
biological activity. In the case of HPIV3 P protein (603 aa long), the
putative oligomerization domain can be found within aa 416 to 457 (7), the role of which in the trimerization process of the
protein will be important to study. Interestingly, P
40N was found to
interact efficiently with wt P, forming a heterooligomer, whereas
P
20C interacted only poorly (Fig. 6), suggesting that the C-terminal
20 aa provide some regulatory role in the oligomerization process (Fig.
6). In this respect, HPIV3 P protein is similar to the measles virus P
protein (507 aa long), in which the C-terminal domain also plays a
regulatory role in P-P interaction (26), although the
putative oligomerization domain is found within aa residues 309 to 341 (7). Analysis of L-P complex formation, however, revealed
that the wt P protein is present in the complex most likely in the trimeric form (Fig. 6), whereas P
40N complexes with L in a higher oligomeric form (5 P
40N per L) and P
20C is weakly complexed with
L and is present at about 1 P
20C per L. Together, these data
strongly suggest that the P protein interacts with L, perhaps in the
monomeric form, and subsequently oligomerizes to form trimers or even
higher-order oligomers. This conclusion is underscored by the findings
that under high P expression conditions, the molar amount of P in the
L-P complex was as high as 6 P per L (data not shown). Thus, it seems
that the core RNA polymerase complex contains a subunit composition of
L and P at 1:1 to stabilize the complex (Fig. 6C); however, P protein
composition changes from monomer to multimeric states
(L-P3-6) in the holoenzyme to maximize the
RNA-synthesizing activity.
The most interesting findings emerged from these studies when we
coexpressed the N- and C-terminally deleted P proteins in the
minigenome replication system in the presence of a suboptimal level of
wt P. Unlike Sendai virus, in which a heterooligomeric complex
containing mutant and wt P proteins inhibited viral transcription in
vitro (6), the HPIV3 P mutants, when present in large excess within the heterooligomeric complex, did not inhibit viral
transcription or replication in vivo, suggesting that the presence of 1 wt P in a heterooligomer is sufficient for the formation of active RNA
polymerase complex. This difference may be due to different systems,
e.g., in vitro and in vivo, used in the two studies or may represent a
major difference between the P proteins of Sendai virus and HPIV3.
Surprisingly, P
40N, which is active in RNA synthesis in vitro,
failed to provide the stoichiometric function in vivo for efficient
minigenome replication in the presence of wt P protein (Fig. 7A). Thus,
the stoichiometric requirement for P in in vivo minigenome replication
is possibly at a step other than RNA synthesis, most likely at the step
of encapsidation. This notion is supported by the previous findings
that the efficiency of luciferase expression in the minigenome
replication system is mostly dependent on the encapsidation of
genome-sense RNA synthesized by viral RNA polymerase and thus
amplification of the minigenome template (17). On the other
hand, P
20C, which is inactive in RNA synthesis in vitro (Fig. 2) but
efficiently forms soluble N-P complex (Fig. 5D), can provide the
stoichiometric function, albeit at a low level, when coexpressed in
stoichiometric amounts with the wt P in the minigenome replication
system. Thus, it is tempting to speculate that within the
heterooligomeric complex, 1 wt P is necessary and sufficient to form a
stable complex with the L protein to form the core enzyme, while
additional P subunits present in the complex seem to be required for
efficient RNA synthesis during transcription and replication.
Similarly, at the level of encapsidation during replication, 1 wt P is
sufficient to form the N-P complex, but additional P subunits in the
heterooligomer are possibly required to efficiently perform the
encapsidation process. Further studies are under way to elucidate the
mechanistic role of various complexes of the P protein of HPIV3 during
viral transcription and replication.
 |
ACKNOWLEDGMENT |
This work was supported by U.S. Public Health Service grant
AI32027 (to A.K.B.).
 |
FOOTNOTES |
*
Corresponding authors. Mailing address: Department of
Virology, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave., NC20, Cleveland, OH 44195. Phone: (216) 444-0625. Fax: (216) 444-0512. E-mail: banerja{at}ccf.org.
 |
REFERENCES |
| 1.
|
Banerjee, A. K.
1987.
Transcription and replication of rhabdoviruses.
Microbiol. Rev.
51:66-87[Free Full Text].
|
| 2.
|
Banerjee, A. K.,
S. Barik, and B. P. De.
1991.
Gene expression of negative strand RNA viruses.
Pharmacol. Ther.
51:47-70[CrossRef][Medline].
|
| 3.
|
Bullough, P. A.,
F. M. Hughson,
J. J. Skehel, and D. C. Wiley.
1994.
Structure of influenza haemagglutinin at the pH of membrane fusion.
Nature
371:37-43[CrossRef][Medline].
|
| 4.
|
Collins, P. L.,
R. M. Chanock, and K. McIntosh.
1996.
Parainfluenza viruses, p. 1205-1241.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 5.
|
Curran, J.
1996.
Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein.
Virology
221:130-140[CrossRef][Medline].
|
| 6.
|
Curran, J.
1998.
A role for the Sendai virus P protein trimer in RNA synthesis.
J. Virol.
72:4274-4280[Abstract/Free Full Text].
|
| 7.
|
Curran, J.,
R. Boeck,
N. Lin-Marq,
A. Lupas, and D. Kolakofsky.
1995.
Paramyxovirus phosphoproteins form homotrimers as determined by an epitope dilution assay, via predicted coiled coils.
Virology
214:139-149[CrossRef][Medline].
|
| 8.
|
Curran, J.,
J. B. Marq, and D. Kolakofsky.
1992.
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis.
Virology
189:647-656[CrossRef][Medline].
|
| 9.
|
Curran, J.,
J. B. Marq, and D. Kolakofsky.
1995.
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication.
J. Virol.
69:849-855[Abstract].
|
| 10.
|
Curran, J.,
T. Pelet, and D. Kolakofsky.
1994.
An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation.
Virology
202:875-884[CrossRef][Medline].
|
| 11.
|
Das, T., and A. K. Banerjee.
1992.
Role of the phosphoprotein (P) in the encapsidation of presynthesized and de novo synthesized vesicular stomatitis virus RNA by the nucleocapsid protein (N) in vitro.
Cell. Mol. Biol.
38:17-26[Medline].
|
| 12.
|
Das, T.,
A. K. Gupta,
P. W. Sims,
C. A. Gelfand,
J. E. Jentoft, and A. K. Banerjee.
1995.
Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA polymerase of vesicular stomatitis virus.
J. Biol. Chem.
270:24100-24107[Abstract/Free Full Text].
|
| 13.
|
De, B. P., and A. K. Banerjee.
1985.
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro.
Biochem. Biophys. Res. Commun.
126:40-49[CrossRef][Medline].
|
| 14.
|
De, B. P.,
A. L. Burdsall, and A. K. Banerjee.
1993.
Role of cellular actin in human parainfluenza virus type 3 genome transcription.
J. Biol. Chem.
268:5703-5710[Abstract/Free Full Text].
|
| 15.
|
De, B. P.,
A. Lesoon, and A. K. Banerjee.
1991.
Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis.
J. Virol.
65:3268-3275[Abstract/Free Full Text].
|
| 16.
|
Dupuy, L. C.,
S. Dobson,
V. Bitko, and S. Barik.
1999.
Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase: phosphorylation by casein kinase I occurs mainly at Ser215 and is without effect.
J. Virol.
73:8384-8392[Abstract/Free Full Text].
|
| 17.
|
Durbin, A. P.,
J. W. Siew,
B. R. Murphy, and P. L. Collins.
1997.
Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and the evaluation of the rule of six.
Virology
234:74-83[CrossRef][Medline].
|
| 18.
|
Errington, W., and P. T. Emmerson.
1997.
Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein.
J. Gen. Virol.
78:2335-2339[Abstract].
|
| 19.
|
Fu, Z. F.,
Y. Zheng,
W. H. Wunner,
H. Koprowski, and B. Deitzschold.
1994.
Both the N- and C-terminal domains of the nominal phosphoprotein of rabies virus are involved in binding to the nucleoprotein.
Virology
200:590-597[CrossRef][Medline].
|
| 20.
|
Galinski, M. S.
1991.
Paramyxoviridae: transcription and replication.
Adv. Virus Res.
39:129-162[Medline].
|
| 21.
|
Galinski, M. S.,
R. M. Troy, and A. K. Banerjee.
1992.
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3.
Virology
186:543-550[CrossRef][Medline].
|
| 22.
|
Galinski, M. S., and S. L. Wechsler.
1990.
Molecular biology of the paramyxovirus genus, p. 41-82.
In
D. W. Kingsbury (ed.), Paramyxoviruses. Plenum Press, New York, N.Y.
|
| 23.
|
Gao, Y.,
N. J. Greenfield,
D. Z. Cleverley, and J. Lenard.
1996.
The transcriptional form of the phosphoprotein of vesicular stomatitis virus is a trimer: structure and stability.
Biochemistry
35:14569-14573[CrossRef][Medline].
|
| 24.
|
Gill, D. S.,
D. Chattopadhyay, and A. K. Banerjee.
1986.
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro.
Proc. Natl. Acad. Sci. USA
83:8873-8877[Abstract/Free Full Text].
|
| 25.
|
Gupta, S.,
B. P. De,
J. A. Drazba, and A. K. Banerjee.
1998.
Involvement of actin microfilaments in the replication of human parainfluenza virus type 3.
J. Virol.
72:2655-2662[Abstract/Free Full Text].
|
| 26.
|
Harty, R. N., and P. Palese.
1995.
Measles virus phosphoprotein (P) requires the NH2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself.
J. Gen. Virol.
76:2863-2867[Abstract/Free Full Text].
|
| 27.
|
Hoffman, M. A., and A. K. Banerjee.
2000.
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3.
Virology
269:201-211[CrossRef][Medline].
|
| 28.
|
Horikami, S. M.,
J. Curran,
D. Kolakofsky, and S. A. Moyer.
1992.
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.
J. Virol.
66:4901-4908[Abstract/Free Full Text].
|
| 29.
|
Horikami, S. M., and S. A. Moyer.
1995.
Alternative amino acids at a single site in the Sendai virus L protein produce multiple defects in RNA synthesis in vitro.
Virology
211:577-582[CrossRef][Medline].
|
| 30.
|
Lamb, R. A.,
B. W. Mahy, and P. W. Choppin.
1976.
The synthesis of Sendai virus polypeptides in infected cells.
Virology
69:116-131[CrossRef][Medline].
|
| 31.
|
Lamb, R. A., and D. Kolakofsky.
1996.
Paramyxoviridae: the viruses and their replication, p. 1177-1204.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 32.
|
Leone, G.,
L. Maybaum, and P. W. Lee.
1992.
The reovirus cell attachment protein possesses two independently active trimerization domains: basis for dominant negative effects.
Cell
71:479-488[CrossRef][Medline].
|
| 33.
|
Luk, D.,
A. Sanchez, and A. K. Banerjee.
1986.
Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic.
Virology
153:318-325[CrossRef][Medline].
|
| 34.
|
Mellon, M. G., and S. U. Emerson.
1978.
Rebinding of transcriptase components (L and NS) proteins to the nucleocapsid template of vesicular stomatitis virus.
J. Virol.
27:560-567[Abstract/Free Full Text].
|
| 35.
|
Nathke, I. S.,
J. Heuser,
A. Lupas,
J. Stock,
C. W. Turck, and F. M. Brodsky.
1992.
Folding and trimerization of clathrin subunits at the triskelion hub.
Cell
68:899-910[CrossRef][Medline].
|
| 36.
|
Nishio, M.,
M. Tsurudome,
M. Ito,
N. Watanabe,
M. Kawano,
H. Komada, and Y. Ito.
1997.
Human parainfluenza virus type 2 phosphoprotein: mapping of monoclonal antibody epitopes and location of the multimerization domain.
J. Gen. Virol.
78:1303-1308[Abstract].
|
| 37.
|
Peteranderl, R., and H. C. M. Nelson.
1992.
Trimerization of the heat shock transcription factor by a triple-stranded a-helical coiled-coil.
Biochemistry
31:12272-12276[CrossRef][Medline].
|
| 38.
|
Ryan, K. W., and D. W. Kingsbury.
1988.
Carboxyl-terminal region of Sendai virus P protein is required for binding to viral nucleocapsids.
Virology
167:106-112[CrossRef][Medline].
|
| 39.
|
Ryan, K. W.,
E. M. Morgan, and A. Portner.
1991.
Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain.
Virology
180:126-134[CrossRef][Medline].
|
| 40.
|
Smallwood, S.,
K. W. Ryan, and S. A. Moyer.
1994.
Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein.
Virology
202:154-163[CrossRef][Medline].
|
| 41.
|
Takacs, A. M.,
T. Das, and A. K. Banerjee.
1993.
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using two-hybrid system.
Proc. Natl. Acad. Sci. USA
90:10375-10379[Abstract/Free Full Text].
|
| 42.
|
Tarbouriech, N.,
J. Curran,
C. Ebel,
R. W. H. Ruigrok, and W. P. Burmeister.
2000.
On the domain structure and the polymerization state of the Sendai virus P protein.
Virology
266:99-109[CrossRef][Medline].
|
| 43.
|
Wilson, I. A.,
J. J. Skehel, and D. C. Wiley.
1981.
Structure of the haemagglutinin glycoprotein of influenza virus at 3Å resolution.
Nature
289:366-373[CrossRef][Medline].
|
| 44.
|
Zhao, H., and A. K. Banerjee.
1995.
Interaction between the nucleocapsid protein and the phosphoprotein of human parainfluenza virus 3.
J. Biol. Chem.
270:12485-12490[Abstract/Free Full Text].
|
Journal of Virology, July 2000, p. 5886-5895, Vol. 74, No. 13
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chen, M., Ogino, T., Banerjee, A. K.
(2007). Interaction of Vesicular Stomatitis Virus P and N Proteins: Identification of Two Overlapping Domains at the N Terminus of P That Are Involved in N0-P Complex Formation and Encapsidation of Viral Genome RNA. J. Virol.
81: 13478-13485
[Abstract]
[Full Text]
-
Moller, P., Pariente, N., Klenk, H.-D., Becker, S.
(2005). Homo-Oligomerization of Marburgvirus VP35 Is Essential for Its Function in Replication and Transcription. J. Virol.
79: 14876-14886
[Abstract]
[Full Text]
-
Schneider, U., Blechschmidt, K., Schwemmle, M., Staeheli, P.
(2004). Overlap of Interaction Domains Indicates a Central Role of the P Protein in Assembly and Regulation of the Borna Disease Virus Polymerase Complex. J. Biol. Chem.
279: 55290-55296
[Abstract]
[Full Text]
-
Kingston, R. L., Baase, W. A., Gay, L. S.
(2004). Characterization of Nucleocapsid Binding by the Measles Virus and Mumps Virus Phosphoproteins. J. Virol.
78: 8630-8640
[Abstract]
[Full Text]
-
Bose, S., Basu, M., Banerjee, A. K.
(2004). Role of Nucleolin in Human Parainfluenza Virus Type 3 Infection of Human Lung Epithelial Cells. J. Virol.
78: 8146-8158
[Abstract]
[Full Text]
-
Chan, Y. P., Koh, C. L., Lam, S. K., Wang, L.-F.
(2004). Mapping of domains responsible for nucleocapsid protein-phosphoprotein interaction of henipaviruses. J. Gen. Virol.
85: 1675-1684
[Abstract]
[Full Text]
-
Bose, S., Mathur, M., Bates, P., Joshi, N., Banerjee, A. K.
(2003). Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol.
84: 1687-1699
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Malur, A. G., Choudhary, S. K., De, B. P., Banerjee, A. K.
(2002). Role of a Highly Conserved NH2-Terminal Domain of the Human Parainfluenza Virus Type 3 RNA Polymerase. J. Virol.
76: 8101-8109
[Abstract]
[Full Text]
-
Tuckis, J., Smallwood, S., Feller, J. A., Moyer, S. A.
(2002). The C-Terminal 88 Amino Acids of the Sendai Virus P Protein Have Multiple Functions Separable by Mutation. J. Virol.
76: 68-77
[Abstract]
[Full Text]
-
Choudhary, S., Gao, J., Leaman, D. W., De, B. P.
(2001). Interferon Action against Human Parainfluenza Virus Type 3: Involvement of a Novel Antiviral Pathway in the Inhibition of Transcription. J. Virol.
75: 4823-4831
[Abstract]
[Full Text]